Vaginal cancer is a rare but serious gynecological malignancy that requires timely diagnosis, precise staging, and expert treatment planning. Because of its uncommon nature, many patients are unfamiliar with its symptoms, risk factors, and available treatment options. Early recognition and specialized oncological management significantly improve outcomes and long-term quality of life.
Dr. Lovedeep Singh Chauhan, Consultant Surgical Oncologist at Max Super Speciality Hospital Mohali, provides comprehensive evaluation and evidence-based treatment for gynecological cancers, including vaginal cancer. With advanced training in complex oncologic surgery and minimally invasive cancer procedures, he offers structured, multidisciplinary cancer care tailored to each patient’s condition.
Vaginal cancer develops in the tissues of the vagina, the muscular canal that connects the cervix to the external genitalia. It is much less common compared to cervical or uterine cancers, but when diagnosed early, it can be treated effectively.
There are two main categories:
Because symptoms may initially be mild or absent, regular gynecological examinations are essential, particularly for postmenopausal women or those with persistent HPV infection.
Each histological type influences treatment planning and prognosis.
This is the most common type, accounting for the majority of cases. It arises from the thin, flat squamous cells lining the vagina and is often associated with persistent Human Papillomavirus (HPV) infection.
A less common type that develops from glandular cells. Certain subtypes may be associated with prenatal exposure to diethylstilbestrol (DES), although this is rare today.
An aggressive but rare cancer arising from pigment-producing cells. It requires specialized surgical planning.
Develops from connective tissues such as muscle or fibrous tissue within the vaginal wall. This form is uncommon but may occur in younger patients.
Although the exact cause is not always identifiable, several established risk factors increase susceptibility:
Persistent infection with high-risk HPV strains is the most significant risk factor. HPV-related cancers often develop gradually over years, beginning as precancerous lesions.
Understanding these risk factors allows for preventive strategies such as HPV vaccination and routine screening.
In early stages, vaginal cancer may not produce noticeable symptoms. As the disease progresses, patients may experience:
Any unexplained vaginal bleeding should never be ignored and warrants prompt evaluation by a specialist.
Early diagnosis plays a decisive role in treatment success. Evaluation typically involves a systematic and evidence-based approach.
A detailed pelvic examination is the first step. Suspicious lesions are carefully assessed for size, location, and involvement of adjacent structures.
This magnified examination allows visualization of abnormal tissue and helps guide biopsy.
A tissue sample confirms the diagnosis and determines the cancer type and grade.
These investigations provide insights into tumor behavior and help guide treatment decisions.
Advanced imaging and pathology services ensure accurate staging before initiating treatment.
Staging is based on the FIGO (International Federation of Gynecology and Obstetrics) classification system.
Cancer confined to the vaginal wall.
Spread to nearby tissues but not to pelvic wall.
Involvement of pelvic wall or regional lymph nodes.
Spread to bladder, rectum, or distant organs.
Accurate staging determines whether surgery, radiation, chemotherapy, or a combination is most appropriate.
Management depends on tumor size, location, histology, stage, and overall patient health. A multidisciplinary tumor board approach ensures optimal planning.
Surgery remains a cornerstone for early-stage disease and selected advanced cases. Procedures may include:
Minimally invasive techniques may be considered when feasible, reducing hospital stay and promoting faster recovery.
Radiation plays a significant role, either as primary treatment or adjuvant therapy. It may involve:
Often administered alongside radiation (chemoradiation) to enhance treatment response, especially in advanced stages.
For selected patients, reconstructive surgery may be offered to restore anatomical structure and improve quality of life following radical procedures.
Vaginal cancer management requires coordination among multiple specialists:
This integrated approach improves precision, safety, and overall treatment outcomes.
Dr. Lovedeep Singh Chauhan is a highly trained Consultant Surgical Oncologist with expertise in gynecological malignancies including cancers of the uterus, ovary, cervix, and vagina.
Cancer care extends beyond surgery. Emotional support, nutritional guidance, and survivorship planning are integral parts of management.
Ongoing care and prevention are key components of managing vaginal cancer effectively.
Regular follow-up visits typically include physical examination and imaging when indicated. Early detection of recurrence improves secondary treatment outcomes.
Preventive healthcare significantly reduces the incidence of HPV-related malignancies.